Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
138 studies found for:    "Acromegaly"
Show Display Options
Rank Status Study
21 Completed
Has Results
Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide capsules
22 Completed Acute Application of Pegvisomant and Octreotide in Acromegaly
Condition: Acromegaly
Interventions: Drug: pegvisomant;   Drug: combination with somatostatin analogue octreotide;   Drug: combination with dopamine agonist cabergoline
23 Not yet recruiting Strict IGF-1 Control in Acromegaly
Condition: Acromegaly
Intervention: Drug: Pegvisomant
24 Terminated Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide
25 Enrolling by invitation Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?
Condition: Acromegaly
Intervention:
26 Active, not recruiting
Has Results
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
Condition: Acromegaly
Interventions: Drug: Pasireotide (SOM230);   Drug: octreotide LAR 30mg;   Drug: lanreotide ATG 120mg
27 Completed
Has Results
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Condition: Acromegaly
Interventions: Drug: Somatuline Autogel (lanreotide acetate);   Behavioral: Home administration
28 Recruiting Late Effects of Radiosurgery on Acromegaly Study
Condition: Acromegaly
Intervention: Device: Gamma Knife radiosurgery
29 Active, not recruiting Validation Study of the SAGIT® Instrument in Acromegaly
Condition: Acromegaly
Intervention:
30 Completed Prediction of Tumor Shrinkage in Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide-LAR
31 Completed Somatuline Autogel: Acromegaly Self/Partner Injection Study
Condition: Acromegaly
Intervention: Drug: Lanreotide (Autogel formulation)
32 Unknown  Effects of Sandostatin LAR® in Acromegaly
Condition: Acromegaly
Intervention: Drug: Sandostatin LAR
33 Active, not recruiting Brain-gut Interaction in Irradiated Patients With Acromegaly
Condition: Acromegaly
Intervention:
34 Completed SAGIT for Classification of Patients With Acromegaly in Clinical Practice
Condition: Acromegaly
Intervention: Other: SAGIT
35 Unknown  Prospective Study on Changes in Acromegaly
Condition: Acromegaly
Intervention:
36 Completed Programme of Acromegaly Screening in Patients With Associated Somatic Disorders
Condition: Acromegaly
Intervention: Other: Non-interventional cross-sectional survey
37 Recruiting IGF-I and Free Fatty Acids Isn Glucose Metabolism in Acromegaly
Condition: Acromegaly
Intervention:
38 Completed Open Label Study of Octreotide Implant in Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: octreotide acetate
39 Recruiting Assessment of Airway in Patients With Acromegaly for Predicting Successful Tracheal Intubation
Condition: Acromegaly
Intervention: Device: Fiberoptic
40 Active, not recruiting Pasireotide LAR and Pegvisomant Study in Acromegaly
Condition: Acromegaly
Interventions: Drug: Pasireotide LAR 60 mg;   Drug: Pegvisomant

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.